Issue 004 | U.S. Pilot | US

RVPH

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Screen state: Passing Source state: Verified 10-Q | 2026-05-13 Filing currency: USD

Open Filing Back to Register Report a correction

Internal NCAV Discount 65.5%

GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.

Current Assets: 23,559,636USD
Total Liabilities: 6,119,155USD
NCAV: 17,440,481USD
Cash: 22,190,231USD
NCAV per share: 1.36USD/share
Evidence: 8 annual | 25 quarterly

Mary filing review

Financial Statement Evidence

Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.

Evaluated: 12
Triggered: 2
Unavailable: 7

Requires inspection Negative OCF -3,801,296

Latest: -3,801,2962026-03-31
Comparison: n/a
Change: n/a

Basis: latest reporting-period cash from operations < 0

Source periods: SEC 10-Q 2026-03-31 · 0001437749-26-016762

Supporting observation Current Ratio > 1.5 3.85

Latest: 3.852026-03-31
Comparison: 1.5
Change: n/a

Basis: current assets / current liabilities; strong if > 1.5

Source periods: SEC 10-Q 2026-03-31 · 0001437749-26-016762

7 unavailable checks — inspect missing inputs

High Debt (short-term debt + long-term debt) / ordinary equity >= 50%

Low Debt (short-term debt + long-term debt) / ordinary equity < 20%

Material 1Y Share Increase 1Y share change >= +2% using the same share-count source

NCAV Growing equivalent prior-year NCAV change >= +2%; both NCAV values must be positive

No Material 1Y Share Increase 1Y share change > -2% and <= +1% using the same share-count source

Non-Positive Equity ordinary shareholders equity <= 0

Share Count Reduced 1Y share change <= -2% using the same share-count source

Business Profile

Published only when a substantive filing-text profile has been prepared for this issue.

Not available for this issue.

A substantive filing-text profile was not prepared for this company. Financial statement evidence and filing links remain available above for direct inspection.

Historical values can be viewed as reported in each filing or normalized to the latest verified split basis. These are measurement aids, not conclusions about a company.

Policy: normalize_to_latest_verified_split_basis | quality: needs review

Display basis Normalized to latest verified split basis As reported in each filing

Metric	2026-03-31 10-Q Open filing	2025-12-31 10-K Open filing	2025-09-30 10-Q Open filing	2025-06-30 10-Q Open filing	2025-03-31 10-Q Open filing	2024-12-31 10-K Open filing	2024-09-30 10-Q Open filing	2024-06-30 10-Q Open filing	2024-03-31 10-Q Open filing	2023-12-31 10-K Open filing	2023-09-30 10-Q Open filing	2023-06-30 10-Q Open filing	2023-03-31 10-Q Open filing	2022-12-31 10-K Open filing	2022-09-30 10-Q Open filing	2022-06-30 10-Q Open filing	2022-03-31 10-Q Open filing	2021-12-31 10-K Open filing	2021-09-30 10-Q Open filing	2021-06-30 10-Q Open filing	2020-12-31 10-K Open filing	2020-02-29 10-K Open filing	2019-02-28 10-K Open filing
Period-end Shares Outstanding	12,810,37712,810,377	5,872,8655,872,865	2,408,42896,337,119	1,700,09068,003,613	1,168,49946,739,949	1,164,48046,579,199	836,03033,441,199	745,43229,817,294	697,96427,918,560	697,96427,918,560	516,25720,650,266	566,25722,650,266	511,30320,452,121	511,18420,447,371	511,07220,442,871	n/an/a	378,33215,133,286	360,83214,433,286	334,72513,388,986	334,72513,388,986	230,7939,231,737	67,6152,704,587	65,0622,602,465
Weighted-average Basic Shares	7,022,9457,022,945	3,627,8903,627,890	1,817,14472,685,740	1,246,19749,847,872	1,216,10848,644,339	828,68633,147,424	845,11733,804,693	763,87530,555,012	747,18329,887,325	594,95523,798,203	600,84224,033,665	560,87022,434,781	545,84021,833,598	487,91219,516,479	481,75019,269,989	461,66518,466,586	461,66518,466,586	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a
Weighted-average Diluted Shares	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a
Basic EPS	-0-0	-5-5	-0-0	-0-0	-0-0	-1-1	-1-1	-1-1	-0-0	-2-2	-1-1	-1-1	-0-0	-1-1	-1-1	-1-1	-0-0	-1-1	-0-0	-0-0	n/an/a	n/an/a	n/an/a
Diluted EPS	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a	n/an/a
Basic-to-Diluted Share Difference	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence	Insufficient evidence
Net Share Count Change	118.1%	143.8%	41.7%	45.5%	0.3%	39.3%	12.2%	6.8%	0.0%	35.2%	-8.8%	10.7%	0.0%	0.0%	Insufficient evidence	0.0%	4.8%	7.8%	0.0%	45.0%	241.3%	3.9%	Insufficient evidence
Ownership Claim Change	-54.2%	-59.0%	-29.4%	-31.3%	-0.3%	-28.2%	-10.8%	-6.4%	0.0%	-26.0%	9.7%	-9.7%	-0.0%	-0.0%	Insufficient evidence	0.0%	-4.6%	-7.2%	0.0%	-31.0%	-70.7%	-3.8%	Insufficient evidence

Verified split events: reverse 2.0 on 2025-12-18; reverse 20.0 on 2026-03-09

Known Unknowns

Medium | Share Count

The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric	2025-12-31 10-K USD	2024-12-31 10-K USD	2023-12-31 10-K USD	2022-12-31 10-K USD	2021-12-31 10-K USD	2020-12-31 10-K USD	2020-02-29 10-K USD	2019-02-28 10-K USD
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-20,200,031	-30,798,889	-39,503,636	-24,306,608	-10,104,513	-2,434,651	-724,740	-152,789
Net Income	-19,864,902	-29,918,802	-39,260,837	-24,339,292	-8,521,876	-3,783,388	617,903	574,131
Cash From Operations	-24,594,643	-33,543,916	-28,324,353	-18,960,581	-10,668,462	-3,725,692	-426,591	-220,869
Capex	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Free Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash And Equivalents	14,438,792	13,476,331	23,367,456	18,519,856	29,687,944	8,760,462	69,276	313,049
Accounts Receivable	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	15,103,477	14,683,367	23,700,388	n/a	n/a	n/a	138,860	404,179
Total Assets	15,923,198	15,503,088	23,700,388	18,923,675	31,404,001	8,762,278	61,021,809	65,646,099
Total Current Liabilities	7,275,553	14,601,506	17,175,017	6,039,840	2,344,811	1,332,743	299,653	23,050
Total Liabilities	7,275,553	14,690,516	17,981,672	6,607,279	2,717,541	1,332,743	3,263,403	2,236,800
Shareholders Equity	8,647,645	812,572	5,718,716	12,316,396	28,686,460	7,429,535	5,000,007	5,000,008
Shares Outstanding	5,872,865	46,579,199	27,918,560	20,447,371	14,433,286	9,231,737	2,704,587	2,602,465
Shares Outstanding Diluted	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Weighted Avg Shares Diluted	3,627,890	33,147,424	23,798,203	19,516,479	14,790,843	3,061,670	2,610,315	2,039,690
Weighted Avg Shares Basic	3,627,890	33,147,424	23,798,203	19,516,479	14,790,843	3,061,670	2,610,315	2,039,690
Net Share Count Change (Normalized)	143.8%	39.3%	35.2%	0.0%	7.8%	241.3%	3.9%	Insufficient evidence
Ownership Claim Change (Normalized)	-59.0%	-28.2%	-26.0%	-0.0%	-7.2%	-70.7%	-3.8%	Insufficient evidence

Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric	2026-03-31 10-Q USD	2025-12-31 10-K USD	2025-12-31 10-K USD	2025-09-30 10-Q USD	2025-06-30 10-Q USD	2025-03-31 10-Q USD	2024-12-31 10-K USD	2024-12-31 10-K USD	2024-09-30 10-Q USD	2024-06-30 10-Q USD	2024-03-31 10-Q USD	2023-12-31 10-K USD	2023-12-31 10-K USD	2023-09-30 10-Q USD	2023-06-30 10-Q USD	2023-03-31 10-Q USD	2022-12-31 10-K USD	2022-12-31 10-K USD	2022-09-30 10-Q USD	2022-06-30 10-Q USD	2022-03-31 10-Q USD	2021-12-31 10-K USD	2021-12-31 10-K USD	2021-09-30 10-Q USD	2021-06-30 10-Q USD
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-3,271,952	-3,559,041	-3,559,041	-4,029,841	-6,072,982	-6,538,167	-6,284,606	-6,284,606	-8,462,534	-8,129,643	-7,922,106	-9,988,485	-9,988,485	-10,709,047	-12,070,551	-6,735,553	-7,774,010	-7,774,010	-3,562,953	-5,519,488	-7,450,157	-3,964,643	-3,965,443	-2,476,840	-1,790,102
Net Income	-3,195,987	-3,367,679	-3,367,679	-4,010,773	-6,053,610	-6,432,840	-6,259,477	-6,259,477	-8,365,798	-7,859,919	-7,433,608	-9,724,403	-9,724,403	-10,491,029	-12,442,862	-6,602,543	-8,118,272	-8,118,272	-3,515,308	-5,340,704	-7,365,008	-3,684,953	-3,684,953	-2,279,216	-1,608,407
Cash From Operations	-3,801,296	-5,798,211	-5,798,211	-5,589,486	-5,012,748	-8,194,198	-9,100,497	-9,100,497	-4,241,422	-8,476,188	-11,725,809	-8,876,445	-8,876,445	-6,179,284	-5,317,227	-7,951,397	-4,690,634	-4,690,634	-4,001,995	-4,001,175	-6,266,777	-3,902,153	-3,902,153	-2,309,325	-1,340,741
Capex	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Free Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash And Equivalents	22,190,231	14,438,792	14,438,792	13,183,259	10,363,714	5,289,404	13,476,331	13,476,331	5,558,817	6,178,180	11,973,647	23,367,456	23,367,456	4,972,298	11,151,582	11,255,552	18,519,856	18,519,856	23,191,927	19,420,062	23,421,237	29,687,944	29,687,944	33,491,616	35,800,941
Total Current Assets	23,559,636	15,103,477	15,103,477	13,512,928	10,815,125	6,257,325	14,683,367	14,683,367	6,810,151	7,232,953	n/a	23,700,388	23,700,388	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Liabilities	6,119,155	7,275,553	7,275,553	9,782,914	12,093,993	11,537,070	14,690,516	14,690,516	17,611,760	14,094,196	14,842,447	17,981,672	17,981,672	13,906,473	10,220,835	7,116,550	6,607,279	6,607,279	3,681,431	4,583,081	3,907,194	2,717,541	2,717,541	1,624,586	2,013,902
Shares Outstanding	12,810,377	5,872,865	5,872,865	96,337,119	68,003,613	46,739,949	46,579,199	46,579,199	33,441,199	29,817,294	27,918,560	27,918,560	27,918,560	20,650,266	22,650,266	20,452,121	20,447,371	20,447,371	20,442,871	14,433,286	15,133,286	14,433,286	14,433,286	13,388,986	13,388,986
Shares Outstanding Diluted	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Weighted Avg Shares Diluted	7,022,945	n/a	3,627,890	72,685,740	49,847,872	48,644,339	n/a	38,279,052	33,804,693	30,555,012	29,887,325	n/a	26,833,239	24,033,665	22,434,781	21,833,598	n/a	21,828,519	19,269,989	18,466,586	18,466,586	n/a	18,459,413	18,455,586	12,874,961
Weighted Avg Shares Basic	7,022,945	3,627,890	3,627,890	72,685,740	49,847,872	48,644,339	33,147,424	38,279,052	33,804,693	30,555,012	29,887,325	23,798,203	26,833,239	24,033,665	22,434,781	21,833,598	19,516,479	21,828,519	19,269,989	18,466,586	18,466,586	14,790,843	18,459,413	18,455,586	12,874,961
Net Share Count Change (Normalized)	118.1%	143.8%	143.8%	41.7%	45.5%	0.3%	39.3%	39.3%	12.2%	6.8%	0.0%	35.2%	35.2%	-8.8%	10.7%	0.0%	0.0%	0.0%	Insufficient evidence	0.0%	4.8%	7.8%	7.8%	0.0%	45.0%
Ownership Claim Change (Normalized)	-54.2%	-59.0%	-59.0%	-29.4%	-31.3%	-0.3%	-28.2%	-28.2%	-10.8%	-6.4%	0.0%	-26.0%	-26.0%	9.7%	-9.7%	-0.0%	-0.0%	-0.0%	Insufficient evidence	0.0%	-4.6%	-7.2%	-7.2%	0.0%	-31.0%

Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input	Value	Source concept	Filing period	Confidence	Provenance
Current Assets	23,559,636USD	us-gaap:AssetsCurrent	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001742927/companyfacts.json Data Vault \| sec/companyfacts/cik=0001742927/companyfacts.json
Total Liabilities	6,119,155USD	us-gaap:Liabilities	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001742927/companyfacts.json Data Vault \| sec/companyfacts/cik=0001742927/companyfacts.json
Cash	22,190,231USD	us-gaap:CashAndCashEquivalentsAtCarryingValue	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001742927/companyfacts.json Data Vault \| sec/companyfacts/cik=0001742927/companyfacts.json
Shares Outstanding	12,810,377	us-gaap:CommonStockSharesOutstanding	2026-03-31	1.00	Data Vault \| sec/companyfacts/cik=0001742927/companyfacts.json Data Vault \| sec/companyfacts/cik=0001742927/companyfacts.json
NCAV	17,440,481USD	derived	2026-03-31	n/a	company-evidence-v1 \| total_current_assets - total_liabilities
NCAV per share	1.36USD	derived	2026-03-31	n/a	company-evidence-v1 \| NCAV / shares_outstanding
Internal NCAV Discount	65.5%	derived	2026-03-31	n/a	gnni_publication_pack \| internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source: Data Vault
Data Vault Root: Local evidence | The Data Vault
CIK: 0001742927
Company ID: n/a
Selected Annual Source: Data Vault | sec/companyfacts/cik=0001742927/companyfacts.json
Selected Quarterly Source: Data Vault | sec/companyfacts/cik=0001742927/companyfacts.json
Statement Extractor: companyfacts-screener-v1
View Extractor: companyfacts-screener-v1
Source Accession Count: 24
Imported At: 2026-08-15T12:52:45+00:00
Rendered At: 2026-08-16T03:29:54+00:00

Run Audit

Mary Run: 29510e1968ca4fb386d55ebe1e97a5de
Mary As Of: 2026-08-01
Accession: 0001437749-26-016762
CIK: 0001742927
Mary Filing Date: 2026-05-13
Filing Currency: USD
Internal Discount: 65.5%
Source State: Verified
Market Context: Not Displayed
Market Policy: internal_only_not_redistributed
Share Trend: Not Evaluated
Dilution: Needs Review

mary_run=29510e1968ca4fb386d55ebe1e97a5de; mary_as_of=2026-08-01; mary_filing_date=2026-05-13; mary_accession=0001437749-26-016762; mary_cik=0001742927; gnni_supporting_filing_date=2026-05-13; internal_discount=0.654776; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Report a correction Archive